Free-standing microchamber arrays as a biodegradable drug depot system for implant coatings / Yu. A. Zykova [et al.]

Уровень набора: European Polymer JournalАльтернативный автор-лицо: Zykova, Yu. A., Yuliya Aleksandrovna;Kudryavtseva, V. L., physicist, Engineer of Tomsk Polytechnic University, 1993-, Valeriya Lvovna;Gay, M., Meyu;Kozelskaya, A. I., physicist, Assistant of Tomsk Polytechnic University, Candidate of physical and mathematical sciences, 1985-, Anna Ivanovna;Frue, Yo. K., Yokhannes Kristof;Sukhorukov, G. B., Gleb Borisovich;Tverdokhlebov, S. I., physicist, Associate Professor of Tomsk Polytechnic University, Candidate of physical and mathematical science, 1961-, Sergei IvanovichКоллективный автор (вторичный): Национальный исследовательский Томский политехнический университет, Инженерная школа новых производственных технологий, Отделение материаловедения;Национальный исследовательский Томский политехнический университет, Инженерная школа ядерных технологий, Научно-образовательный центр Б. П. ВейнбергаЯзык: английский.Резюме или реферат: The combination of an efficient encapsulation method of small water-soluble substances with a stimuli-responsive release of defined quantity remains a challenging task. A novel drug delivery system (DDS) representing a free-standing PLLA microchamber arrays film and its application as the cover for implantable endovascular stent are reported in this work. The proposed DDS preparation method is consisting of a patterned polydimethylsiloxane (PDMS)-stamp dip-coated into a polymer solution followed by drug loading and sealing it by polymer pre-coated substrate. It was shown that using 1?wt% PLLA solution is optimal for obtaining microchamber arrays with an individual cargo capacity of 2.88?Ч?10-9 µg, which was successfully loaded by model drug substance Rhodamine B. Rhodamine B was completely released in vitro during 13?days in PBS at 37?°C by diffusion. It was demonstrated that low-frequency ultrasound (LFUS, 20?kHz) allows triggering RhB release due to microchamber damage and detachment of individual PLLA microchambers over time. LFUS exposure time up to 25?s led to RhB release of up to 8.4?Ч?10-4 µg (approximately 55%) from microchambers located on the flat substrate; up to 5.2?Ч?10-4 µg from microchambers located on the stent with using a simplified vessel model. Furthermore, the free-standing printed PLLA microchamber arrays were demonstrated to be applied as endovascular stent cover that can be used for complementary pharmacological effect, for example, triggered local delivery of anticoagulants..Примечания о наличии в документе библиографии/указателя: [References: 63 tit.].Аудитория: .Тематика: электронный ресурс | труды учёных ТПУ | polylactic acid | drug delivery system | controlled release | low-frequency ultrasound | stimuli-responsive | endovascular stent | полимолочная кислота | доставка | лекарства | низкочастотные сигналы Ресурсы он-лайн:Щелкните здесь для доступа в онлайн
Тэги из этой библиотеки: Нет тэгов из этой библиотеки для этого заглавия. Авторизуйтесь, чтобы добавить теги.
Оценка
    Средний рейтинг: 0.0 (0 голосов)
Нет реальных экземпляров для этой записи

Title screen

[References: 63 tit.]

The combination of an efficient encapsulation method of small water-soluble substances with a stimuli-responsive release of defined quantity remains a challenging task. A novel drug delivery system (DDS) representing a free-standing PLLA microchamber arrays film and its application as the cover for implantable endovascular stent are reported in this work. The proposed DDS preparation method is consisting of a patterned polydimethylsiloxane (PDMS)-stamp dip-coated into a polymer solution followed by drug loading and sealing it by polymer pre-coated substrate. It was shown that using 1?wt% PLLA solution is optimal for obtaining microchamber arrays with an individual cargo capacity of 2.88?Ч?10-9 µg, which was successfully loaded by model drug substance Rhodamine B. Rhodamine B was completely released in vitro during 13?days in PBS at 37?°C by diffusion. It was demonstrated that low-frequency ultrasound (LFUS, 20?kHz) allows triggering RhB release due to microchamber damage and detachment of individual PLLA microchambers over time. LFUS exposure time up to 25?s led to RhB release of up to 8.4?Ч?10-4 µg (approximately 55%) from microchambers located on the flat substrate; up to 5.2?Ч?10-4 µg from microchambers located on the stent with using a simplified vessel model. Furthermore, the free-standing printed PLLA microchamber arrays were demonstrated to be applied as endovascular stent cover that can be used for complementary pharmacological effect, for example, triggered local delivery of anticoagulants.

Для данного заглавия нет комментариев.

оставить комментарий.